Syncom Formul.

{
  "main_header": {
    "sid": 831770,
    "name": "Syncom Formul.",
    "stock_name": "Syncom Formul.",
    "full_name": "Syncom Formulations (India) Ltd",
    "name_url": "stocks-analysis/syncom-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "13.82",
    "chg": 0.45,
    "chgp": "3.37%",
    "dir": 1,
    "prev_price": "13.37",
    "mcapval": "1,296.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 524470,
    "symbol": "SYNCOMF",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE312C01025",
    "curr_date": "Apr 15",
    "curr_time": "",
    "bse_nse_vol": "25.68 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 15, 2026",
    "traded_date_str": "2026 04 15",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syncom-formul-831770-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Syncom Formulations (India) Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3938730",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyncomFormulati_technicaldot_3938730.png",
        "date": "2026-04-09 08:04:41",
        "description": "Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a strong day gain of 7.02%, the stock’s overall momentum and technical indicators present a nuanced picture that investors should carefully analyse."
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3934185",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/SyncomFormulati_mojoScore_3934185.png",
        "date": "2026-04-06 10:10:28",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Why is Syncom Formulations (India) Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-syncom-formulations-india-ltd-fallingrising-3926885",
        "imagepath": "",
        "date": "2026-03-31 01:38:48",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Syncom Formulations hit a new 52-week low of ₹10.21 on the day, underscoring the persistent weakness in its share price. The stock has been on a consecutive two-day losing streak, registering a cumulative decline of 10.9% during this period. This recent underperformance is sharper than the sector average, with the stock lagging by 4.41% relative to its peers on the same day.</p>\n<p>Examining the stock’s returns against the broader market reveals a concerning trend. Over the past week, Syncom Formulations has declined by 8.36%, significantly underperforming the Sensex’s modest 1.03% fall. The one-month and year-to-date figures further highlight the stock’s struggles, with losses of 16.19% and 27.82% respectively, compared to the Sen..."
      },
      {
        "title": "Markets Rally, But Syncom Formulations Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-amid-market-downturn-3924567",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_priceRelatedfactors_3924567.png",
        "date": "2026-03-30 11:49:29",
        "description": "Despite a broader market rebound, Syncom Formulations (India) Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 10.45 on 30 Mar 2026. The stock’s recent decline contrasts sharply with the market’s tentative recovery, underscoring company-specific challenges that continue to weigh on investor sentiment."
      },
      {
        "title": "Markets Rally, But Syncom Formulations (India) Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-of-rs1097-3919755",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_priceRelatedfactors_3919755.png",
        "date": "2026-03-27 13:22:55",
        "description": ""
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3917838",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_mojoScore_3917838.png",
        "date": "2026-03-26 10:10:26",
        "description": "Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook."
      },
      {
        "title": "Markets Rally, But Syncom Formulations Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-of-rs1105-3910052",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_priceRelatedfactors_3910052.png",
        "date": "2026-03-24 10:07:46",
        "description": "While the broader market showed signs of recovery, Syncom Formulations (India) Ltd slipped to a fresh 52-week low of Rs 11.05 on 24 Mar 2026, extending a downward trajectory that has seen the stock lose nearly 38% over the past year."
      },
      {
        "title": "Markets Rally, But Syncom Formulations (India) Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syncom-formulations-india-ltd-falls-to-52-week-low-of-rs1128-3907828",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_priceRelatedfactors_3907828.png",
        "date": "2026-03-23 12:30:14",
        "description": ""
      },
      {
        "title": "Syncom Formulations (India) Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syncom-formulations-india-ltd-is-rated-sell-3892101",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SyncomFormulati_mojoScore_3892101.png",
        "date": "2026-03-15 10:10:23",
        "description": "Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      }
    ],
    "total": 266,
    "sid": "831770",
    "stock_news_url": "https://www.marketsmojo.com/news/syncom-formulations-india-831770"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "07-Apr-2026",
      "details": "Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) Regulation 2018 for the quarter ended 31st March 2026",
      "source": "BSE"
    },
    {
      "caption": "Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A",
      "datetime": "07-Apr-2026",
      "details": "<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=1px><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Syncom Formulations India Ltd-</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L24239MH1988PLC047759</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December as applicable (in Rs cr)</td> <td>0.00</td></tr> <tr><td>4</td><td>Highest Credit Rating during the previous FY </td><td>NA</td></tr> <tr><td>4a</td><td>Name of the Credit Rating Agency issuing the Credit Rating mentioned in (4)</td><td>Not Applicable</td></tr> <tr><td>5</td><td>Name of Stock Exchange# in which the fine shall be paid in case of shortfall in the required borrowing under the framework</td><td>BSE</td></tr> </table> <br/><br/> <div> <div style=float:left;> We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26 2018. No</div> <br/><br/><br/> <div style=float:left;> Name of the Company Secretary: VAISHALI AGRAWAL <br/> Designation: COMAPNY SECRETARY <br/> EmailId: finance@sfil.in</div> <div style=float:left;margin-left:50px;> Name of the Chief Financial Officer: RAHUL VIJAY BANKDA <br/> Designation: CHIEF FINANCIAL OFFICER <br/> EmailId: finance@sfil.in</div> </div> <div> <br/> Date: 07/04/2026<br/><br/> <b>Note:<b> In terms para of 3.2(ii) of the circular beginning F.Y 2022 in the event of shortfall in the mandatory borrowing through debt securities a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore an entity identified as LC shall provide in its initial disclosure for a financial year the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets. </div>",
      "source": "BSE"
    },
    {
      "caption": "Forwarding Yearly Disclosure Under Regulation 31(4) Of SEBI (SAST) Regulations 2011 By The Promoters Along With Their Person Acting In Concert(PAC) Of The Company For The Financial Year Ended On 31St March 2026.",
      "datetime": "06-Apr-2026",
      "details": "Pursuant to the regulation 31(4) of SEBI (SAST) Regulations 2011 we would like to inform that the following promoters along with their persons acting in concert have provided a copy of the yearly disclosure for the financial year ended on 31st March 2026.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has declared <strong>3%</strong> dividend, ex-date: 09 Sep 22",
          "dt": "2022-09-09",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:10</strong> stock split, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>5:2</strong> bonus issue, ex-date: 19 Aug 13",
          "dt": "2013-08-19",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Syncom Formulations (India) Ltd has announced <strong>1:2</strong> rights issue, ex-date: 13 May 09",
          "dt": "2009-05-13",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Syncom Formulations (India) Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-04-09 08:04:41

Syncom Formulations (India) Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical parameters, reflecting a complex interplay of bullish and bearish signals. Despite a strong day gain of 7.02%, the stock’s overall momentum and technical indicators present a nuanced picture that investors should carefully analyse.

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-04-06 10:10:28

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Why is Syncom Formulations (India) Ltd falling/rising?

2026-03-31 01:38:48

Recent Price Movement and Market Performance

Syncom Formulations hit a new 52-week low of ₹10.21 on the day, underscoring the persistent weakness in its share price. The stock has been on a consecutive two-day losing streak, registering a cumulative decline of 10.9% during this period. This recent underperformance is sharper than the sector average, with the stock lagging by 4.41% relative to its peers on the same day.

Examining the stock’s returns against the broader market reveals a concerning trend. Over the past week, Syncom Formulations has declined by 8.36%, significantly underperforming the Sensex’s modest 1.03% fall. The one-month and year-to-date figures further highlight the stock’s struggles, with losses of 16.19% and 27.82% respectively, compared to the Sen...

Read full news article

Markets Rally, But Syncom Formulations Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-30 11:49:29

Despite a broader market rebound, Syncom Formulations (India) Ltd has succumbed to selling pressure, hitting a fresh 52-week low of Rs 10.45 on 30 Mar 2026. The stock’s recent decline contrasts sharply with the market’s tentative recovery, underscoring company-specific challenges that continue to weigh on investor sentiment.

Read full news article

Markets Rally, But Syncom Formulations (India) Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-27 13:22:55

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-03-26 10:10:26

Syncom Formulations (India) Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 12 February 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 26 March 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.

Read full news article

Markets Rally, But Syncom Formulations Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-24 10:07:46

While the broader market showed signs of recovery, Syncom Formulations (India) Ltd slipped to a fresh 52-week low of Rs 11.05 on 24 Mar 2026, extending a downward trajectory that has seen the stock lose nearly 38% over the past year.

Read full news article

Markets Rally, But Syncom Formulations (India) Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-23 12:30:14

Read full news article

Syncom Formulations (India) Ltd is Rated Sell

2026-03-15 10:10:23

Syncom Formulations (India) Ltd is rated Sell by MarketsMOJO. This rating was last updated on 12 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

View All News